Strides Pharma Science Ltd Half Yearly Results

Gross Sales

2,340.57

2,344.06

2,221.28

1,960.71

1,929.42

Excise Duty

0

0

0

0

0

Net Sales

2,340.57

2,344.06

2,221.28

1,960.71

1,929.42

Other Operating Income

0

0

0

0

0

Other Income

35.72

-10.41

3,323.74

44.8

44.49

Total Income

2,376.29

2,333.65

5,545.01

2,005.51

1,973.91

Total Expenditure

1,909.01

1,913.64

1,848.89

1,694.96

1,855.79

PBIDT

467.28

420.01

3,696.13

310.54

118.12

Interest

93.59

102.5

146.35

125.22

155.01

PBDT

373.69

317.51

3,549.78

185.32

-36.88

Depreciation

98.53

97.28

94.98

93.95

119.7

Minority Interest Before NP

0

0

0

0

0

Tax

33.62

16.23

30.68

11.27

21.11

Deferred Tax

4.42

28.33

2.27

15.61

-18.87

Reported Profit After Tax

237.12

175.66

3,421.85

64.5

-158.82

Minority Interest After NP

9.98

5.52

-1.46

-3.34

-20.36

Net Profit after Minority Interest

227.14

170.14

3,423.32

67.84

-138.46

Extra-ordinary Items

-14.77

-29.84

3,270.94

31.45

-149.8

Adjusted Profit After Extra-ordinary item

241.91

199.98

152.38

36.39

11.34

EPS (Unit Curr.)

24.64

18.46

372.4

7.38

-15.33

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

92.17

92.16

91.96

91.9

90.33

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

19.96

17.91

166.39

15.83

6.12

PBDTM(%)

-

-

-

-

-

PATM(%)

10.13

7.49

154.04

3.28

-8.23